This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Università Degli Studi Di Roma "La Sapienza", Universitá Degli Studi Di Siena. Active years: 2018.
Company Filing History:
1 out of 63 
1 out of 18 Years Active: 2018
Title: Lucia Di Marcotullio: Innovator in Hedgehog Pathway Inhibitors
Introduction
Lucia Di Marcotullio is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of cancer research, particularly through her innovative work on Hedgehog pathway inhibitors. Her research focuses on developing compounds that can selectively inhibit the activity of the Hedgehog (Hh) pathway, which is crucial in treating Hh-dependent tumors.
Latest Patents
Lucia holds a patent for "Multitarget hedgehog pathway inhibitors and uses thereof." This invention concerns compounds that selectively inhibit the activity of the Hedgehog pathway. The compounds are particularly useful in treating tumors such as medulloblastoma, which is a type of brain cancer. Lucia's patent represents a significant advancement in targeted cancer therapies.
Career Highlights
Throughout her career, Lucia has been associated with prestigious institutions, including the Università Degli Studi Di Roma "La Sapienza" and the Università Degli Studi Di Siena. Her work has not only contributed to academic knowledge but has also paved the way for potential therapeutic applications in oncology.
Collaborations
Lucia has collaborated with notable colleagues in her field, including Bruno Botta and Alberto Gulino. These partnerships have enhanced her research and contributed to the development of innovative solutions in cancer treatment.
Conclusion
Lucia Di Marcotullio is a trailblazer in the field of cancer research, with her innovative patents and collaborations marking her as a significant figure in the scientific community. Her work continues to inspire advancements in targeted therapies for cancer treatment.